Author:
Ye Christine,Sweeny David,Sukbuntherng Juthamas,Zhang Qingling,Tan Weiwei,Wong Simon,Madan Ajay,Ogilvie Brian,Parkinson Andrew,Antonian Lida
Subject
Toxicology,General Medicine
Reference27 articles.
1. Biotransformation of the anti-angiogenic compound SU5416;Antonian;Drug Metabolism and Disposition,2000
2. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal;Benjamin;Proceedings of the National Academy of Sciences,1997
3. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine;Brown,1997
4. Pharmacokinetics and pharmacodynamics of SU5416 in a phase I, dose-escalating trial in patients with advanced malignancies;Cropp;Proceedings of the American Society of Clinical Oncologist,1999
5. Overview of angiogenesis: biologic implications for antiangiogenic therapy;Ellis;Seminars in Oncology,2001
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献